医学
类风湿性关节炎
滑膜炎
纳米医学
纳米生物技术
生物相容性材料
疾病
内科学
纳米技术
生物医学工程
纳米颗粒
材料科学
作者
Naila Qamar,Ammara Arif,Attya Bhatti,Peter John
出处
期刊:Rheumatology
[Oxford University Press]
日期:2019-06-20
卷期号:58 (10): 1715-1721
被引量:20
标识
DOI:10.1093/rheumatology/kez286
摘要
Abstract RA is a multifactorial autoimmune inflammatory disease characterized by synovitis, bone destruction and joint dysfunction that leads to shortening of lifespan and increased mortality rates. Currently available treatments of RA, by controlling various symptoms, only delay disease progression and have their own side effects. Consequently, there is the need for a novel therapeutic strategy that offers a more sustainable and biocompatible solution. Nanomedicine is a modern branch of nanobiotechnology that provides targeted therapy to inflamed rheumatic joints and thus prevents unwanted off-target side effects. This review highlights various nanotheranostic and nanotherapeutic strategies that are currently being used for the treatment of RA.
科研通智能强力驱动
Strongly Powered by AbleSci AI